School of Medicine
Showing 9,711-9,720 of 12,891 Results
-
Kristin Sainani (n e Cobb)
Professor (Teaching) of Epidemiology and Population Health
Current Research and Scholarly InterestsScience writing, science communication, biostatistics. Research areas: osteoporosis, stress fractures, sports injuries, female athlete triad.
-
Neetu Saini
Postdoctoral Scholar, Stem Cell Transplantation
BioMy research interests focus on translational human T-cell immunology, with an emphasis on regulatory T cells (Tregs) and their therapeutic potential in restoring immune tolerance and tissue homeostasis. I am particularly interested in engineering FOXP3-programmed CD4⁺ T cells as a stable and functional alternative to conventional Tregs, especially in inflammatory settings where endogenous Tregs may be unstable or dysfunctional. My work integrates gene-editing approaches, immunophenotyping, and human organoid systems to study how these engineered cells interact with epithelial and stem cell compartments, with a focus on mechanisms of tissue repair and immune–epithelial crosstalk in barrier tissues such as the intestine. Moving forward, I aim to advance next-generation cell therapies by combining insights from T-cell biology, tissue biology, and disease modeling to develop durable and clinically relevant strategies for treating immune-mediated and epithelial barrier disorders.
-
Hamed Sajjadi, MD, FACS
Staff, OHNS/Otolaryngology/Head & Neck Surgery
Clinical Professor (Affiliated), OHNS/Otology & Neurotology DivisionCurrent Role at StanfordClinical Professor, supervising residents and medical students at Palo Alto VA health care system on a weekly basis.
-
Debbie C. Sakaguchi Sakai
Clinical Professor, Pediatrics
Current Research and Scholarly InterestsMedical education, shared decision making, resuscitation.
-
Kathleen M. Sakamoto
Shelagh Galligan Professor in the School of Medicine
Current Research and Scholarly InterestsMy research focuses on the molecular pathways that regulate normal and aberrant blood cell development, including acute leukemia and bone marrow failure syndromes. We are also studying novel drugs for treatment of cancer.
